Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Assets Average (2016 - 2025)

Historic Assets Average for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $238.5 million.

  • Lifecore Biomedical, Inc. \De\'s Assets Average fell 463.13% to $238.5 million in Q2 2025 from the same period last year, while for May 2025 it was $238.5 million, marking a year-over-year decrease of 463.13%. This contributed to the annual value of $246.7 million for FY2025, which is 279.86% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Assets Average stood at $238.5 million for Q2 2025, which was down 463.13% from $246.5 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Assets Average ranged from a high of $504.4 million in Q2 2021 and a low of $238.5 million during Q2 2025
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Assets Average value was $253.7 million (recorded in 2023), while the average stood at $311.5 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Assets Average surged by 1958.2% in 2021 and then tumbled by 4283.99% in 2022.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Assets Average (Quarter) stood at $433.0 million in 2021, then crashed by 37.38% to $271.2 million in 2022, then fell by 9.39% to $245.7 million in 2023, then rose by 2.19% to $251.1 million in 2024, then decreased by 5.01% to $238.5 million in 2025.
  • Its Assets Average stands at $238.5 million for Q2 2025, versus $246.5 million for Q1 2025 and $251.1 million for Q4 2024.